Abstract
Phenacemide (Phenurone, phenylacetylurea) was the prototype of the first group of anticonvulsant substances to depart from the traditional barbiturate, hydantoin, and oxazolidinedione ring structures characteristic of antiepileptic drugs in use prior to 1948. These noncyclic ureides may be considered analogues of their corresponding ring structures. Thus, phenacemide is a straight-chain analogue of 5-phenylhydantoin (opened between the number-5 carbon and the adjacent nitrogen). Other antiepileptic straight-chain analogues of hydantoins, available in various countries, include pheneturide (Benuride), chlorphenacemide (Comitia- don), and acetylpheneturide (Crampol).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albertson TE, Peterson SL, Stark LG (1980) Anticonvulsant drugs and their antagonism of kindled amygdaloid seizures in rats. Neuropharmacology 19: 643–652
Asher DT, Taylor JD, Richards RK (1953) Excretion of radioactive C14 by rats given C14-phenurone (phenacetylurea). Fed Proc 12: 299
Ashton D, Wauquier A (1979) Behavioral analysis of the effects of 15 anticonvulsants in the amygdaloid kindled rat. Psychopharmacology 65: 7–13
Babington RG, Wedeking PW (1973) The pharmacology of seizures induced by sensitization with low intensity brain stimulation. Pharmacol Biochem Behav 1: 461–467
Camerman A, Camerman N (1977) Ethylphenacemide and phenacemide: Conformational similarities to diphenylhydantoin and stereochemical basis of anticonvulsant activity. Proc Natl Acad Sci USA 74: 1264–1266
Close WJ, Spielman MA (1961) Anticonvulsant drugs. In: Hartung WH (ed) Medicinal chemistry, vol 5. Wiley, New York, pp 1–349
Coatsworth J J, Penry KJ (1972) General principles: clinical efficacy and use. In: Woodbury DM, Penry KJ, Schmidt RP (eds) Antiepileptic drugs. Raven, New York, pp 87–96
Consroe P, Kudray K. Schmitz R (1980) Acute and chronic antiepileptic drug effects in audiogenic seizure-susceptible rats. Exp Neurol 70: 626–637
Davidson DLW, Tsukada Y, Barbeua A (1978) Quabain induced seizures: site of production and response to anticonvulsants. J Can Sci Neurol 5: 405–41
Davidson DT, Lennox WG (1950) Phenacetylurea - phenurone - in epilepsy. Dis Nerv Syst 11: 167–173
Everett GM (1949) Pharmacological studies on phenacetylurea (phenurone), an anticonvulsant drug. Fed Proc 8: 289
Everett GM, Richards RK (1952) Pharmacological studies of phenacetylurea (phenurone), an anticonvulsant drug. J Pharmacol Exp Ther 106: 303–311
Field JB, Justi RA (1954) Fatal hepatitis after phenurone therapy for epilepsy. N Engl J Med 251: 147–149
Forster FM, Frankel K (1949) Fatal aplastic anemia during anti-convulsant therapy. Dis Nerv Syst 10: 108–111
Frommel E, Gold-Aubert P, Fleury C (1959) Pharmacological study of dextrorotatory and levorotatory pheneturide. Arch Int Pharmacodyn Ther 122: 15–31
Galeazzi RL, Egli M, Wad N (1979) Pharmacokinetics of phenylethylacetylurea (pheneturide), an old antiepileptic drug. J Pharmacokinet Biopharm 7: 453–462
Gibbs FA, Everett GM, Richards RK (1949) Phenurone in epilepsy. Dis Nerv Syst 10: 2–4
Glasson B, Lerch P, Benakis A (1960) Metabolisme et excretion comparee de quelque medicaments anticonvulsant. Therapie 18: 1483–1491
Hazard R, Cheymol J, Chabrier P, Smarzewska K (1951) Action anticonvulsivante et structure moleculaire de quelques composes heterocycliques pentagonaux. VIII. Influence de pouserture du noyau. Comptes Rendus Hebdomadaires des Seances de l’A-cademie des Science 232: 658–660
Houghton GW, Richens A (1974) The effect of benzodiazepines and pheneturide on phenytoin metabolism in man. Br J Clin Pharmacol 1: 344–345
Huisman JW, Van Heycop Ten Ham MW, Van Zijl CHW (1970) Influence of ethyl-phenacemide on serum levels of other antiepileptic drugs. Epilepsia 11: 207–215
Job C, Lindinger H, Zellner H (1954) Phenyl-alpha-chloracetylharnstoff ( Comitiadon) ein neues Antiepileptikum bei psychomotorischen und petit-mal-Anfallen. Wien Med Wochenschr 104: 911–917
Krall RL, Penry JK, White BG, Kupferberg HJ, Swinyard EA (1978) Antiepileptic drug development. II. Anticonvulsant drug screening. Epilepsia 19: 409–428
Latham AN, Richens A (1973) Pheneturide, a more potent liver enzyme inducer in man than phenobarbitone? Br J Clin Pharmacol 47: 615
Latham AN, Sweeney GD (1967) Binding of anticonvulsant drugs to cytochrome P-450: Correlation with evidence of induction of hepatic microsomal enzymes. Can J Physiol Pharmacol 54: 844–849
Levy RW, Simons DJ, Aronson S (1950) Fatal hepatorenal syndrome associated with phenurone therapy. N Engl J Med 243: 933–936
Liversedge LA, Yates PO, Lempert H (1952) Acute yellow atrophy of the liver following treatment with phenylacetylurea. Lancet 1: 242–243
Livingston S, Kajdi L (1950) The use of phenurone in the treatment of epilepsy. J Pediatr 36: 159–164
Mercier J (1973) Chemical compounds possessing anticonvulsant activity. Structure-activity relationships. International Encyclopedia of Pharmacology and Therapeutics: 203–238
Murray WJ, Kier LB (1977) Noncyclic anticonvulsants. In: Vida JA (ed) Medicinal chemistry, vol 15. Wiley, New York, pp 577–619
Nakamura K, Kurebe M (1962) Differential effects of anti-epileptic drugs on hippocampal and pallidal after-discharge in cats. Jpn J Pharmacol 12: 180–190
Nakamura K, Murai K, Nakatsuji K, Kobayashi M, Masuda Y, Kadokawa T, Soji Y, Nakamura H, Hirooka T, Senda H (1968) Neuropharmacological and toxicological studies on a new anti-epileptic, N-α-ethyl-phenylacetyl-N-acetyl urea, in experimental animals. Arzneimittelforsch 18: 524–529
Orloff MK, Feldman PE, Shaiova CH, Pfeiffer CC (1951) Anticonvulsant and toxic effects of alpha-phenyl-butyryl urea. Neurology 1: 377–385
Peters JJ, Vonderahe AR (1953) Effect of themisone and phenurone on electrically-induced seizures in salamander. Neurology 3: 890–895
Richards RK (1979) Effects of phenacemide and primidone on plasma creatinine in humans and experimental animals. Naunyn Schmiedebergs Arch Pharmacol 308:(Suppl)R25
Richards RK (1980) Structure-activity relationships in the effects of phenacemide analogs on serum creatinine and anticonvulsant activity. Arch Int Pharmacodyn Ther 244: 107–112
Richards RK, Bjornsson TD, Waterbury LD (1978) Rise in serum and urine creatinine after phenacemide. Clin Pharmacol Ther 23: 430–437
Rising TJ (1979) Effects of hepatic microsomal enzyme inducers on the endogenous substrates vitamin D3 and folate in rat. Biochem Pharmacol 28: 63–67
Roldan CM, Rabadan FP, Galan J (1977) Modification of clonazepam anticonvulsive activity by its association with other anti-epileptic drugs. Experientia 33: 640–642
Simpson TW, Wilson EB, Zimmerman SL (1950) Fatal aplastic anemia occurring during anticonvulsant therapy: probable idiosyncrasy to phenurone. Ann Intern Med 32: 1224–1228
Spielman MA (1948) Some anticonvulsants. First National Medicinal Chemistry Symposium of the American Chemical Society, Ann Arbor, Michigan, p 119
Spielman MA, Geiszler AO, Close WJ (1948) Anticonvulsant drugs. II. Some acylureas. J Am Chem Soc 70: 4189–4191
Stoughton RW (1938) Diacylureas. I. Preparation and properties of diacylureas derived from normal aliphatic acids. J Org Chem 2: 514–521
Strotzka VH (1955) Ein neues Antiepileptikum (Comitiadon). Wien Med Wochenschr 105: 137–139
Swinyard EA (1949) Laboratory assay of clinically effective antiepileptic drugs. J Am Pharm Assoc Sci Ed 38: 201–204
Swinyard EA, Brown WC, Goodman LS (1952) Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 106: 319–330
Swinyard EA, Toman JEP (1950) A comparison of the anticonvulsant actions of some phenylhydantoins and their corresponding phenylacetylureas. J Pharmacol Exp Ther 100: 151–157
Swinyard EA, Madsen J A, Goodman LS (1954) The effect of β-diethylaminoethylpropylacetate (SKF No. 525A) on the anticonvulsant properties of antiepileptic drugs. J Pharmacol Exp Ther 111: 54–63
Tatsumi K, Yoshimura H, Tsukamoto H (1967) Metabolism of drugs - LVI. The metabolic fate ofphenacetylurea. Chem Pharm Bull (Tokyo) 16: 1941–1951
Tatsumi K, Yoshihara S, Yamato C, Yoshimura H, Tsukamoto H (1969) Metabolism of drugs. LXIV. Species differences of metabolism of phenacetylurea. Chem Pharm Bull (Tokyo) 17: 1629–1635
Tyler MW, King EQ (1951) Phenacemide in treatment of epilepsy. JAMA 147: 17–21
Volwiler EH, Tabern DL (1936) Some alkyl and aryl amides and ureides as hypnotics. J Am Chem Soc 58: 1352–1354
Weaver LC, Swinyard EA, Goodman LS (1958) Anticonvulsant drug combinations: Diphenylhydantoin combined with other antiepileptics. J Am Pharm Assoc Sci Ed 47: 645–648
Werner EA (1916) The constitution of carbamides. Part III. The reaction of urea and thiourea with acetic anhydride. J Chem Soc 109: 1127
Young DS, Pestaner LC, Gibberman V (1975) Effects of drugs on clinical laboratory tests. Clin Chem 21: 1–3
Zeifert M (1949) Phenurone in epilepsy. Dis Nerv Syst 10: 245–248
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Swinyard, E.A. (1985). Acetylurea Derivatives. In: Frey, HH., Janz, D. (eds) Antiepileptic Drugs. Handbook of Experimental Pharmacology, vol 74. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69518-6_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-69518-6_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69520-9
Online ISBN: 978-3-642-69518-6
eBook Packages: Springer Book Archive